Last reviewed · How we verify

NCT04288180: SAVR

Social Anxiety Virtual Reality Study

Terminated Last updated 8 October 2021
What this trial tests

trial testing No intervention in Social Anxiety Disorder in 4 participants. Terminated before completion.

Timeline
15 January 2020
Primary endpoint
28 February 2020
28 February 2020

Quick facts

Lead sponsorStanford University
StatusTerminated
Study typeOBSERVATIONAL
Enrollment4
Start date15 January 2020
Primary completion28 February 2020
Estimated completion28 February 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Stanford University

Who can join

18 and older, any sex, with Social Anxiety Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project aims to validate a virtual reality paradigm that assesses maladaptive avoidance behavior in social anxiety disorder. It also aims to generate a significant scientific advance by testing the hypothesis that maladaptive avoidance maintains anxiety through disruptions in safety learning.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other recruiting trials for Social Anxiety Disorder

Currently open trials in the same condition.

Other Stanford University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04288180.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing